The stock of Opko Health Inc (OPK) has increased by 33.06% when compared to last closing price of $1.24.Despite this, the company has seen a gain of 36.36% in its stock price over the last five trading days. fool.com reported 2026-07-28 that Investors were also cheered by a substantial narrowing of the company’s net loss. Ditto for the raised full-year revenue guidance.
Is It Worth Investing in Opko Health Inc (OPK) Right Now?
The 36-month beta value for OPK is at 1.52. Analysts have varying views on the stock, with 2 analysts rating it as a “buy”, 2 rating it as “overweight”, 2 as “hold”, and 0 as “sell”.
The public float for OPK is 372.69M, and currently, shorts hold a 9.03% of that float. The average trading volume for OPK on July 29, 2026 was 2.91M shares.
OPK’s Market Performance
OPK’s stock has seen a 36.36% increase for the week, with a 7.84% rise in the past month and a 37.50% gain in the past quarter. The volatility ratio for the week is 8.39%, and the volatility levels for the past 30 days are at 5.35% for Opko Health Inc The simple moving average for the past 20 days is 24.11% for OPK’s stock, with a 27.43% simple moving average for the past 200 days.
OPK Trading at 21.11% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 2.80% of gains for the given period.
Volatility was left at 5.35%, however, over the last 30 days, the volatility rate increased by 8.39%.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPK starting from PAGANELLI JOHN A, who purchase 10,000 shares at the price of $1.14 back on Mar 20 ’26. After this action, PAGANELLI JOHN A now owns 394,340 shares of Opko Health Inc, valued at $11,350 using the latest closing price.
FROST PHILLIP MD ET AL, the CEO & Chairman of Opko Health Inc, purchase 580,000 shares at $1.33 during a trade that took place back on Nov 21 ’25, which means that FROST PHILLIP MD ET AL is holding 216,706,448 shares at $768,807 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -0.25% for the present operating margin
- 0.42% for the gross margin
The net margin for Opko Health Inc stands at -0.12%. The total capital return value is set at -0.09%. Equity return is now at value -5.88%, with -3.83% for asset returns.
Based on Opko Health Inc (OPK), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -0.88. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -6.61.
Currently, EBITDA for the company is $-41.3 million with net debt to EBITDA at -5.82. When we switch over and look at the enterprise to sales, we see a ratio of 1.85. The receivables turnover for the company is 7.18for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.35.
Conclusion
In conclusion, Opko Health Inc (OPK) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
